Advertisement
Grab your lab coat. Let's get started
Welcome!
Welcome!
Create an account below to get 6 C&EN articles per month, receive newsletters and more - all free.
It seems this is your first time logging in online. Please enter the following information to continue.
As an ACS member you automatically get access to this site. All we need is few more details to create your reading experience.
Not you? Sign in with a different account.
Not you? Sign in with a different account.
ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Business
BMS Invests In Puerto Rican Site
by Michael McCoy
July 16, 2012
| A version of this story appeared in
Volume 90, Issue 29
Bristol-Myers Squibb will spend $164 million to expand its site in Humacao, P.R. To be completed by early 2016, the project is expected to add 82,000 sq ft of manufacturing space for type 2 diabetes drugs and 83,150 sq ft for cardiovascular medicines. In addition, the firm says it will debut a new “active coating” process that introduces active ingredients into the coating of a tablet. In 2008, BMS closed its pharmaceutical chemical plant in Barceloneta, P.R. The following year it completed a $200 million expansion in Manati, P.R.
The power is now in your (nitrile gloved) hands
Sign up for a free account to get more articles. Or choose the ACS option that’s right for you.
Already have an ACS ID? Log in
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter